IperionX Limited (IPX) Stock Forecast
IPX analyst forecast
as of October 17, 2026- Analyst consensus
- Strong buy 5.00 / 5 from 6 analysts
- Price target
- $42.50 average of analyst targets
- Upside to target
- +199.3% from the latest close
- Next earnings
- —
- 52-week range
- $13.98 – $60.11
IPX analyst ratings
6 analystsNumber of analysts at each rating.
IPX price target
The average of analyst 12-month price targets compared with the latest close and the 52-week range.
IPX earnings per share estimates
| Period | Average | Low | High | Year ago | Growth | Analysts |
|---|---|---|---|---|---|---|
| Current quarter (Sep '26) | −$0.33 | −$0.33 | −$0.33 | — | — | 1 |
| Next quarter (Dec '26) | −$0.29 | −$0.29 | −$0.29 | — | — | 1 |
| Current fiscal year (FY2027) | −$1.02 | −$1.16 | −$0.89 | −$2.00 | +48.8% | 2 |
| Next fiscal year (FY2028) | $1.53 | $1.53 | $1.53 | −$1.02 | +249.3% | 1 |
Consensus EPS estimates; growth compares the average estimate with the year-ago EPS.
IPX revenue estimates
| Period | Average | Low | High | Growth | Analysts |
|---|---|---|---|---|---|
| Current quarter (Sep '26) | $7.9M | $6.0M | $9.8M | — | 2 |
| Next quarter (Dec '26) | $9.5M | $7.0M | $11.9M | — | 2 |
| Current fiscal year (FY2027) | $7.9M | $7.9M | $7.9M | 0.0% | 1 |
| Next fiscal year (FY2028) | $103.2M | $35.0M | $159.0M | +1,207.3% | 5 |
IPX EPS: reported and forecast
Fiscal years; "E" marks estimates, the line shows the range from the lowest to the highest estimate.
IPX revenue: reported and forecast
IPX EPS estimate revisions
| Period | 90 days ago | 60 days ago | 30 days ago | 7 days ago | Now | Change (90 d) | Revisions (30 d) |
|---|---|---|---|---|---|---|---|
| Current quarter (Sep '26) | −$0.33 | −$0.33 | −$0.33 | −$0.33 | −$0.33 | 0.0% | 0 up · 0 down |
| Next quarter (Dec '26) | −$0.29 | −$0.29 | −$0.29 | −$0.29 | −$0.29 | 0.0% | 0 up · 0 down |
| Current fiscal year (FY2027) | −$0.70 | −$0.70 | −$0.70 | −$0.70 | −$1.02 | +45.7% | 1 up · 0 down |
| Next fiscal year (FY2028) | $0.25 | $0.80 | $0.80 | $0.80 | $1.53 | +512.0% | 0 up · 0 down |
How the consensus EPS estimate changed over the last 90 days, and how many analysts raised or lowered it in the last 30 days.
IPX earnings surprises
Reported EPS vs the consensus estimate for the last 12 quarters; IPX beat in 8 of 12.
What analysts expect from IPX
6 analysts cover IperionX; their consensus rating is strong buy (5.00 on a 1–5 scale, where 5 is a strong buy). The average price target is $42.50, 199.3% above the latest close of $14.20. Analysts expect earnings of −$1.02 per share for FY2027, +48.8% from a year earlier. For FY2028 the average estimate is $1.53 per share on revenue of $103.2 million. IperionX beat the EPS estimate in 8 of the last 12 quarters.
Related: IPX income statement, IPX key metrics, IPX chart. See the IPX stock overview for the latest quote and news.
IPX forecast FAQ
What is IperionX's price target?
The average analyst price target for IperionX is $42.50, 199.3% above the latest close of $14.20.
Is IperionX a buy, hold or sell?
Of 6 analysts covering IperionX, 6 rate it a strong buy, 0 a buy, 0 a hold, 0 a sell and 0 a strong sell, a consensus of strong buy. Ratings are opinions, not a recommendation from Quotelinks.
What is IperionX's EPS forecast?
Analysts forecast −$1.02 per share for FY2027 (range −$1.16 to −$0.89); for FY2028 the estimate is $1.53.
What is IperionX's revenue forecast?
The average revenue estimate for FY2027 is $7.9 million, growth of 0.0%; for FY2028 it is $103.2 million.
Does IperionX usually beat earnings estimates?
IperionX reported EPS at or above the analyst estimate in 8 of the last 12 quarters.